Payment overview · 2025
General Payments
$108.76
1 reported records · 1 companies
Healthcare provider profile · identity verified
Manjula Thopcherla, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LAKEWOOD, NJ · NPI 1598782930
Verified facts
What the public records show
CMS Open Payments records show Manjula Thopcherla, M.D. received $108.76 in general payments during 2025 across 1 reported records.
Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 295 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Mounjaro by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $108.76 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $108.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $108.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
295 | 80 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1533 | 373 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1304 | 331 |
| Losartan Potassium | Losartan Potassium | 1075 | 264 |
| Amlodipine Besylate | Amlodipine Besylate | 897 | 244 |
| Metoprolol Succinate | Metoprolol Succinate | 883 | 236 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 850 | 261 |
| Pantoprazole Sodium | Pantoprazole Sodium | 832 | 265 |
| Furosemide | Furosemide | 731 | 181 |
| Famotidine | Famotidine | 615 | 225 |
| Alprazolam | Alprazolam | 606 | 147 |
| Potassium Chloride | Potassium Chloride | 595 | 167 |
| Gabapentin | Gabapentin | 538 | 119 |
| Donepezil Hcl | Donepezil Hcl | 529 | 100 |
| Escitalopram Oxalate | Escitalopram Oxalate | 512 | 147 |
| Montelukast Sodium | Montelukast Sodium | 511 | 121 |
| Simvastatin | Simvastatin | 481 | 125 |
| Eliquis | Apixaban | 469 | 87 |
| Lisinopril | Lisinopril | 372 | 95 |
| Tamsulosin Hcl | Tamsulosin Hcl | 351 | 80 |
| Sertraline Hcl | Sertraline Hcl | 328 | 91 |
| Omeprazole | Omeprazole | 327 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 307 | 94 |
| Duloxetine Hcl | Duloxetine Hcl | 303 | 96 |
| Trazodone Hcl | Trazodone Hcl | 302 | 94 |
| Jardiance | Empagliflozin | 295 | 80 |
| Metoprolol Tartrate | Metoprolol Tartrate | 278 | 67 |
| Allopurinol | Allopurinol | 275 | 53 |
| Metformin Hcl | Metformin Hcl | 272 | 67 |
| Xarelto | Rivaroxaban | 251 | 28 |
| Prednisone | Prednisone | 249 | 159 |
| Mirtazapine | Mirtazapine | 238 | 68 |
| Fluticasone Propionate | Fluticasone Propionate | 233 | 111 |
| Memantine Hcl | Memantine Hcl | 231 | 53 |
| Synthroid | Levothyroxine Sodium | 221 | 52 |
| Cefuroxime | Cefuroxime Axetil | 216 | 169 |
| Ezetimibe | Ezetimibe | 212 | 70 |
| Buspirone Hcl | Buspirone Hcl | 209 | 50 |
| Azithromycin | Azithromycin | 206 | 155 |
| Carvedilol | Carvedilol | 206 | 42 |
| Methylprednisolone | Methylprednisolone | 186 | 115 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 184 | 40 |
| Hydralazine Hcl | Hydralazine Hcl | 166 | 63 |
| Valsartan | Valsartan | 164 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 163 | 81 |
| Clopidogrel | Clopidogrel Bisulfate | 160 | 47 |
| Amoxicillin | Amoxicillin | 158 | 121 |
| Metformin Hcl Er | Metformin Hcl | 155 | 49 |
| Midodrine Hcl | Midodrine Hcl | 154 | 39 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 152 | 31 |
| Ozempic | Semaglutide | 143 | 20 |
| Atenolol | Atenolol | 141 | 38 |
| Divalproex Sodium | Divalproex Sodium | 138 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 136 | 40 |
| Sucralfate | Sucralfate | 133 | 40 |
| Alendronate Sodium | Alendronate Sodium | 132 | 43 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 129 | 73 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 128 | 15 |
| Bupropion Xl | Bupropion Hcl | 124 | 38 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 120 | 69 |
| Dantrolene Sodium | Dantrolene Sodium | 120 | suppressed |
| Lorazepam | Lorazepam | 118 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 112 | 91 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 112 | 38 |
| Glipizide Er | Glipizide | 108 | 26 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 105 | 78 |
| Torsemide | Torsemide | 105 | 39 |
| Doxycycline Hyclate | Doxycycline Hyclate | 102 | 71 |
| Finasteride | Finasteride | 102 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 102 | 31 |
| Spironolactone | Spironolactone | 101 | 32 |
| Paroxetine Hcl | Paroxetine Hcl | 99 | 21 |
| Januvia | Sitagliptin Phosphate | 93 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 91 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 87 | 25 |
| Clonazepam | Clonazepam | 86 | 14 |
| Nifedipine Er | Nifedipine | 79 | 26 |
| Primidone | Primidone | 79 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 79 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 76 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 76 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 74 | 22 |
| Glipizide | Glipizide | 74 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 69 | 41 |
| Glimepiride | Glimepiride | 66 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 64 | 19 |
| Irbesartan | Irbesartan | 62 | 18 |
| Methotrexate | Methotrexate Sodium | 62 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 59 | 20 |
| Myrbetriq | Mirabegron | 58 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 57 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 57 | 16 |
| Ramipril | Ramipril | 56 | 18 |
| Nystatin | Nystatin | 55 | 34 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 54 | 20 |
| Levofloxacin | Levofloxacin | 54 | 44 |
| Meclizine Hcl | Meclizine Hcl | 51 | 20 |
| Levetiracetam | Levetiracetam | 50 | 12 |
| Entresto | Sacubitril/Valsartan | 49 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 36 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 48 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 46 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 14 |
| Promethazine Hcl | Promethazine Hcl | 45 | 34 |
| Naproxen | Naproxen | 43 | 35 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 32 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 43 | 15 |
| Chlorthalidone | Chlorthalidone | 42 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Temazepam | Temazepam | 42 | 12 |
| Enalapril Maleate | Enalapril Maleate | 41 | 12 |
| Farxiga | Dapagliflozin Propanediol | 41 | 12 |
| Lidocaine | Lidocaine | 40 | 11 |
| Bumetanide | Bumetanide | 39 | 11 |
| Diltiazem 24hr Er | Diltiazem Hcl | 39 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 39 | 11 |
| Fluocinonide | Fluocinonide | 39 | 26 |
| Lovastatin | Lovastatin | 39 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 39 | 38 |
| Pregabalin | Pregabalin | 39 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 37 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 36 | 11 |
| Dexlansoprazole Dr | Dexlansoprazole | 36 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 36 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 36 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 35 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 34 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Fluconazole | Fluconazole | 31 | 20 |
| Rivastigmine | Rivastigmine Tartrate | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 30 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 29 | 12 |
| Celecoxib | Celecoxib | 29 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 19 |
| Amantadine | Amantadine Hcl | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 28 | 12 |
| Repaglinide | Repaglinide | 28 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Nyamyc | Nystatin | 27 | 17 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 20 |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 19 |
| Colchicine | Colchicine | 23 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 14 |
| Megestrol Acetate | Megestrol Acetate | 22 | 12 |
| Mupirocin | Mupirocin | 22 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 22 | 12 |
| Diazepam | Diazepam | 21 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Lacosamide | Lacosamide | 20 | suppressed |
| Modafinil | Modafinil | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Cyclosporine | Cyclosporine | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Prolia | Denosumab | 18 | 14 |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Atovaquone | Atovaquone | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Levoxyl | Levothyroxine Sodium | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Acetazolamide Er | Acetazolamide | 16 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 16 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Meloxicam | Meloxicam | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Procrit | Epoetin Alfa | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Gemtesa | Vibegron | 14 | suppressed |
| Linezolid | Linezolid | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 11 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 14 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Mesalamine Er | Mesalamine | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Klonopin | Clonazepam | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Alphagan P | Brimonidine Tartrate | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $108.76 · 1 records | Lilly USA, LLC | KISUNLA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error